Indication

Familial hypokalemic periodic paralysis

Familial hypokalemic periodic paralysis is a rare, autosomal dominant neuromuscular channelopathy primarily affecting skeletal muscle, typically manifesting during late childhood or adolescence. Read more about Familial hypokalemic periodic paralysis

5 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Familial hypokalemic periodic paralysis therapies.

Showing 1–5 of 5 drugs

DICHLORPHENAMIDE

CARBONIC ANHYDRASE INHIBITORS·FAMILIAL HYPERKALEMIC PERIODIC PARALYSIS·+1
TORRENT PHARMAC

DICHLORPHENAMIDE

CARBONIC ANHYDRASE INHIBITORS·FAMILIAL HYPERKALEMIC PERIODIC PARALYSIS·+1
RISING PHARM
Filter & compare in the drug finder →Opens the drug finder with Familial hypokalemic periodic paralysis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Familial hypokalemic periodic paralysis.

Familial hypokalemic periodic paralysis is a rare, autosomal dominant neuromuscular channelopathy primarily affecting skeletal muscle, typically manifesting during late childhood or adolescence.

It is predominantly caused by pathogenic variants in genes encoding voltage-gated calcium or sodium channels, such as CACNA1S and SCN4A, which disrupt sarcolemmal membrane excitability.

Pathophysiologically, aberrant ion conductance leads to paradoxical muscle cell depolarization and an abnormal intracellular shift of potassium.

Clinically, the disorder is characterized by reversible, episodic attacks of flaccid muscle weakness or paralysis—most notably involving the proximal limbs—concomitant with serum hypokalemia, frequently provoked by rest following strenuous exercise, carbohydrate-rich meals, or physiological stress.

Personalize your experience

Follow Familial hypokalemic periodic paralysis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it